Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 0.800 Q1 | 202 | 400 | 1146 | 53423 | 5306 | 1047 | 4.20 | 133.56 | |
2 | Current Pharmaceutical Design | journal | 0.571 Q2 | 183 | 434 | 1532 | 41393 | 5157 | 1411 | 3.07 | 95.38 | |
3 | Mini-Reviews in Medicinal Chemistry | journal | 0.512 Q2 | 107 | 181 | 393 | 19853 | 1484 | 386 | 3.51 | 109.69 | |
4 | Current Neuropharmacology | journal | 1.722 Q1 | 103 | 145 | 278 | 19000 | 2463 | 258 | 7.25 | 131.03 | |
5 | Current Topics in Medicinal Chemistry | journal | 0.628 Q2 | 133 | 209 | 713 | 17357 | 2292 | 582 | 2.88 | 83.05 | |
6 | Current Organic Chemistry | journal | 0.379 Q3 | 112 | 131 | 462 | 15061 | 951 | 432 | 1.97 | 114.97 | |
7 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.490 Q3 | 63 | 245 | 388 | 14788 | 1033 | 376 | 2.43 | 60.36 | |
8 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.403 Q3 | 108 | 206 | 647 | 13625 | 1619 | 632 | 2.26 | 66.14 | |
9 | Current Drug Targets | journal | 0.654 Q2 | 119 | 139 | 451 | 13590 | 1581 | 431 | 2.91 | 97.77 | |
10 | Coronaviruses | journal | 7 | 166 | 17 | 9589 | 23 | 10 | 1.35 | 57.77 | ||
11 | Current Molecular Pharmacology | journal | 0.729 Q2 | 49 | 106 | 94 | 8305 | 359 | 90 | 3.87 | 78.35 | |
12 | Current Drug Delivery | journal | 0.460 Q2 | 72 | 132 | 299 | 8176 | 959 | 287 | 3.59 | 61.94 | |
13 | CNS and Neurological Disorders - Drug Targets | journal | 0.561 Q2 | 96 | 77 | 227 | 8044 | 744 | 213 | 2.79 | 104.47 | |
14 | Combinatorial Chemistry and High Throughput Screening | journal | 0.244 Q4 | 70 | 168 | 286 | 7962 | 396 | 262 | 1.42 | 47.39 | |
15 | Current Diabetes Reviews | journal | 0.505 Q3 | 68 | 102 | 237 | 7636 | 638 | 231 | 2.62 | 74.86 | |
16 | Current Protein and Peptide Science | journal | 0.602 Q2 | 96 | 72 | 343 | 7634 | 1110 | 312 | 2.90 | 106.03 | |
17 | Current Analytical Chemistry | journal | 0.300 Q3 | 38 | 102 | 265 | 7450 | 516 | 254 | 1.85 | 73.04 | |
18 | Current Stem Cell Research and Therapy | journal | 0.572 Q2 | 63 | 66 | 239 | 7444 | 774 | 223 | 3.12 | 112.79 | |
19 | Current Alzheimer Research | journal | 0.707 Q2 | 103 | 100 | 370 | 7354 | 1307 | 356 | 2.87 | 73.54 | |
20 | Current Medical Imaging | journal | 0.242 Q3 | 37 | 183 | 377 | 7345 | 447 | 362 | 1.26 | 40.14 | |
21 | Current Nutrition and Food Science | journal | 0.206 Q3 | 32 | 108 | 303 | 6607 | 281 | 299 | 0.83 | 61.18 | |
22 | Current Cancer Drug Targets | journal | 0.732 Q2 | 103 | 72 | 243 | 6575 | 863 | 231 | 2.78 | 91.32 | |
23 | Mini-Reviews in Organic Chemistry | journal | 0.318 Q3 | 43 | 73 | 162 | 6341 | 335 | 154 | 2.03 | 86.86 | |
24 | Current Nanoscience | journal | 0.310 Q3 | 52 | 76 | 225 | 6153 | 385 | 218 | 1.62 | 80.96 | |
25 | Current Bioinformatics | journal | 0.461 Q3 | 38 | 122 | 271 | 6015 | 1089 | 256 | 4.71 | 49.30 | |
26 | Current Vascular Pharmacology | journal | 0.670 Q2 | 69 | 60 | 233 | 5338 | 657 | 196 | 3.27 | 88.97 | |
27 | Infectious Disorders - Drug Targets | journal | 0.319 Q3 | 61 | 152 | 210 | 5134 | 317 | 200 | 1.30 | 33.78 | |
28 | Current Bioactive Compounds | journal | 0.211 Q3 | 31 | 79 | 256 | 4876 | 279 | 249 | 1.06 | 61.72 | |
29 | Letters in Drug Design and Discovery | journal | 0.213 Q3 | 37 | 96 | 421 | 4819 | 462 | 397 | 1.01 | 50.20 | |
30 | Current Pharmaceutical Analysis | journal | 0.177 Q3 | 27 | 114 | 308 | 4818 | 196 | 303 | 0.59 | 42.26 | |
31 | Medicinal Chemistry | journal | 0.323 Q3 | 50 | 96 | 254 | 4780 | 536 | 247 | 2.05 | 49.79 | |
32 | Emirates Journal of Food and Agriculture | journal | 0.273 Q3 | 43 | 111 | 351 | 4779 | 504 | 349 | 1.27 | 43.05 | |
33 | Current Drug Discovery Technologies | journal | 0.301 Q4 | 49 | 74 | 152 | 4631 | 284 | 148 | 1.68 | 62.58 | |
34 | Letters in Organic Chemistry | journal | 0.181 Q4 | 33 | 112 | 406 | 4551 | 319 | 372 | 0.78 | 40.63 | |
35 | Current Genomics | journal | 0.596 Q3 | 77 | 52 | 189 | 4495 | 542 | 163 | 2.56 | 86.44 | |
36 | Nanoscience and Nanotechnology - Asia | journal | 0.192 Q3 | 17 | 65 | 179 | 4140 | 183 | 173 | 0.98 | 63.69 | |
37 | Current Cardiology Reviews | journal | 0.551 Q2 | 58 | 61 | 134 | 3948 | 378 | 121 | 2.05 | 64.72 | |
38 | Open Dentistry Journal | journal | 0.290 Q3 | 37 | 108 | 307 | 3790 | 413 | 294 | 0.99 | 35.09 | |
39 | Current Organic Synthesis | journal | 0.330 Q3 | 55 | 58 | 233 | 3781 | 470 | 220 | 2.18 | 65.19 | |
40 | Current Proteomics | journal | 0.155 Q4 | 27 | 65 | 134 | 3625 | 80 | 124 | 0.61 | 55.77 | |
41 | Current Gene Therapy | journal | 0.656 Q2 | 80 | 40 | 123 | 3569 | 493 | 107 | 4.28 | 89.23 | |
42 | Recent Patents on Mechanical Engineering | journal | 0.166 Q4 | 16 | 49 | 98 | 3556 | 61 | 98 | 0.63 | 72.57 | |
43 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.629 Q2 | 52 | 42 | 88 | 3536 | 322 | 85 | 2.84 | 84.19 | |
44 | Recent Patents on Engineering | journal | 0.145 Q4 | 21 | 79 | 154 | 3306 | 66 | 143 | 0.35 | 41.85 | |
45 | Current Computer-Aided Drug Design | journal | 0.258 Q3 | 32 | 82 | 151 | 3213 | 217 | 142 | 1.53 | 39.18 | |
46 | Current Neurovascular Research | journal | 0.459 Q3 | 60 | 65 | 196 | 3136 | 421 | 182 | 1.90 | 48.25 | |
47 | Recent Patents on Nanotechnology | journal | 0.271 Q3 | 36 | 26 | 79 | 2951 | 172 | 75 | 2.21 | 113.50 | |
48 | Anti-Infective Agents | journal | 0.160 Q4 | 26 | 61 | 84 | 2602 | 61 | 81 | 0.80 | 42.66 | |
49 | Current Pediatric Reviews | journal | 0.588 Q2 | 33 | 33 | 107 | 2574 | 384 | 99 | 3.35 | 78.00 | |
50 | Current Cancer Therapy Reviews | journal | 0.117 Q4 | 17 | 29 | 74 | 2524 | 26 | 65 | 0.41 | 87.03 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®